Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The central nervous system (CNS) is an important target of HIV, and cerebrospinal fluid (CSF) can provide a window into host-virus interactions within the CNS. The goal of this study was to determine whether HIV-specific CD8(+) T cells are present in CSF of HIV controllers (HC), who maintain low to undetectable plasma viremia without antiretroviral therapy (ART). CSF and blood were sampled from 11 HC, defined based on plasma viral load (VL) consistently below 2,000 copies/ml without ART. These included nine elite controllers (EC, plasma VL <40 copies/ml) and two viremic controllers (VC, VL 40-2,000 copies/ml). All controllers had CSF VL <40 copies/ml. Three comparison groups were also sampled: six HIV noncontrollers (NC, VL >10,000 copies/ml, no ART); seven individuals with viremia suppressed due to ART (Tx, VL <40 copies/ml); and nine HIV-negative controls. CD4(+) and CD8(+) T cells in CSF and blood were analyzed by flow cytometry to assess expression of CCR5, activation markers CD38 and HLA-DR, and memory/effector markers CD45RA and CCR7. HIV-specific CD8(+) T cells were quantified by major histocompatibility complex class I multimer staining. HIV-specific CD8(+) T cells were detected ex vivo at similar frequencies in CSF of HC and noncontrollers; the highest frequencies were in individuals with CD4 counts below 500 cells/μl. The majority of HIV-specific CD8(+) T cells in CSF were effector memory cells expressing CCR5. Detection of these cells in CSF suggests active surveillance of the CNS compartment by HIV-specific T cells, including in individuals with long-term control of HIV infection in the absence of therapy.

Original publication

DOI

10.1089/aid.2015.0313

Type

Journal article

Journal

AIDS research and human retroviruses

Publication Date

08/2016

Volume

32

Pages

791 - 800

Addresses

1 Department of Medical Microbiology and Immunology, University of California , Davis, Davis, California.

Keywords

CD8-Positive T-Lymphocytes, Humans, HIV-1, Viremia, HIV Infections, Receptors, CCR5, RNA, Viral, HLA-DR Antigens, Anti-HIV Agents, CD4 Lymphocyte Count, Antiretroviral Therapy, Highly Active, Viral Load, Lymphocyte Activation, Gene Expression, Receptors, CCR7, Host-Pathogen Interactions, Disease Resistance, Leukocyte Common Antigens, ADP-ribosyl Cyclase 1